Related Experiment Videos
[Indications for influenza vaccination in children with lung disorders. Dutch Association for Pediatric Medicine]
H J Neijens1, P H Rothbarth, M J Sprenger
1Afd. Kindergeneeskunde, subafd. Infectie-en Immuunziekten, Academisch Ziekenhuis Rotterdam-Sophia Kinderziekenhuis.
Insights
Annual influenza vaccination is recommended for children with moderate to severe asthma. While not proven to have long-term asthma benefits, it is safe and effective for these children.
Area of Science:
- Pediatric Medicine
- Infectious Diseases
- Respiratory Health
Context:
- Influenza virus is a common cause of respiratory infections in children over two years old.
- Children with pulmonary disease, particularly asthma, face risks of exacerbations and prolonged symptoms from influenza.
- Existing guidelines address influenza vaccination for pediatric patients with lung conditions.
Purpose:
- To outline recommendations for influenza vaccination in children with pulmonary disease, specifically focusing on asthma.
- To inform healthcare providers about the safety and efficacy of influenza vaccines in this vulnerable pediatric population.
Summary:
- The Dutch Association for Paediatric Medicine recommends annual influenza vaccination for children with moderate to severe asthma requiring treatment.
- Influenza vaccination in children with pulmonary disease shows effects comparable to healthy children, with no demonstrated long-term positive impact on asthma.
- A booster dose is advised if the first vaccination occurs before age six, with full doses administered in all cases.
Impact:
- Provides clear guidance for pediatricians on managing influenza risk in children with asthma.
- Aims to reduce influenza-related morbidity in children with moderate to severe pulmonary conditions.
- Contributes to public health strategies for preventing severe respiratory illness in pediatric populations.
Abstract:
The Dutch Association for Paediatric Medicine has formulated guidelines regarding influenza vaccination of children with pulmonary disease. Influenza virus is the most frequent cause of airway infections in humans over two years of age. It may lead to serious morbidity in children with pulmonary disease: exacerbations, (transient) disturbances in pulmonary function, and symptoms lasting weeks, but mortality is probably very low. The effects of influenza vaccination of children with pulmonary disease are similar to those in normal healthy children. A positive long-term effect on the asthma has never been demonstrated. It is advised that children with moderate to severe asthma who require treatment to be vaccinated against influenza every year. If the first vaccination ever occurs before the age of six years, it should be followed by a booster vaccination after four weeks. In both instances, a full vaccination dose should be administered.